We hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...
Read moreAs we enter 2022, we are approaching the two-year anniversary of the COVID-19 pandemic spreading acr...
Read moreReviewing previous HTA submissions can provide valuable insights that can help manufacturers prepare...
Read moreIn the US, an Act recently passed through the House of Representatives which plans to expand afforda...
Read morePatent cliff refers to a sharp decline in revenue or profitability when a firm’s patents expire, o...
Read moreThis educational blog will explore what a GMA team does strategically and operationally across the l...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreOur experts reflect on the pricing and market access trends that shaped the European Landscape in 20...
Read moreIs the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...
Read moreThe purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.
Read more